Induction of specific allograft immunity by soluble class I MHC heavy chain protein produced in a baculovirus expression system

Transplantation
M WangB D Kahan

Abstract

Spodoptera frugiperda (Sf9) insect cells secreted a class I MHC RT1.Aa heavy chain protein when infected with baculovirus that bore a construct that contained a honeybee melittin secretion (ms) signal attached to RT1.Aa cDNA. The RT1.Aa heavy chain protein in the culture supernatant and cell lysate immunoprecipitated in the presence of 5 individual anti-RT1.Aa-specific mAb. As was revealed by densitometric analysis, the ms signal increased the production (7- to 17-fold) and secretion (20- to 47-fold) of RT1.Aa protein by Sf9 cells (compared with RT1Aa-Sf9 cells without the ms signal). Subcutaneous immunization with secreted RT1.Aa heavy chain protein of Wistar-Furth (WF; RT1u) rats (day -4) accelerated the rejection of ACI (RT1a), but not third-party Brown Norway (BN; RT1n), heart allografts from 5.9 +/- 0.5 days in controls to 4.0 +/- 0.0 days (P < 0.001); cell lysate from RT1.Aa-Sf9 or ms/RT1.Aa-Sf9 cells reduced ACI heart allograft survival to 3.8 +/- 0.4 days or 3.7 +/- 0.5 days, respectively (P < 0.001). Indirect presentation of RT1.Aa heavy chain proteins by syngeneic macrophages shortened the survival of RT1.Aa-disparate PVG.R8 (RT1.AaDuBuCu) heart allografts in PVG.1U (RT1u) hosts from 6.3 +/- 0.5 days in controls to 4....Continue Reading

References

Jan 1, 1990·Annual Review of Biochemistry·P J Bjorkman, P Parham
Dec 1, 1990·The Journal of Experimental Medicine·J A GracieJ A Bradley
Mar 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·C RadaJ C Howard
Dec 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·M A FrohmanG R Martin
Dec 1, 1973·Transplantation·S LeeM J Orloff
Jan 1, 1984·Immunological Reviews·N L AscherR L Simmons
Aug 1, 1984·Transplantation·L J Perloff, C F Barker
Jan 1, 1993·Annual Review of Immunology·H G RammenseeO Rötzschke
Jan 1, 1993·Annual Review of Immunology·L A Sherman, S Chattopadhyay
Jan 1, 1993·Annual Review of Immunology·R N Germain, D H Margulies
Nov 29, 1955·Proceedings of the Royal Society of London. Series B, Containing Papers of a Biological Character·D B AMOSZ B MIKULSKA

❮ Previous
Next ❯

Citations

Sep 6, 2002·Journal of Immunological Methods·Xiao-Ning Xu, Gavin R Screaton
May 20, 1999·Transplantation Proceedings·M WangB D Kahan
Dec 23, 2006·Molecular Reproduction and Development·Michael FantRoger Bick
Aug 18, 2001·The Journal of Immunology : Official Journal of the American Association of Immunologists·S M O'HerrinJ A Bluestone

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.